Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients

Jesus E. Escamilla, Spenser E. January, Rodrigo Vazquez Guillamet

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Fungal infections are a significant source of morbidity in the lung transplant population via direct allograft damage and predisposing patients to the development of chronic lung allograft dysfunction. Prompt diagnosis and treatment are imperative to limit allograft damage. This review article discusses incidence, risk factors, and symptoms with a specific focus on diagnostic and treatment strategies in the lung transplant population for fungal infections caused by Aspergillus, Candida, Coccidioides, Histoplasma, Blastomyces, Scedosporium/Lomentospora, Fusarium, and Pneumocystis jirovecii. Evidence for the use of newer triazole and inhaled antifungals to treat isolated pulmonary fungal infections in lung transplant recipients is also discussed.

Original languageEnglish
Article number694
Issue number5
StatePublished - May 2023


  • antifungals
  • fungal infections
  • lung transplant


Dive into the research topics of 'Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients'. Together they form a unique fingerprint.

Cite this